CalPERS approves 7.2% increase in HMO rates as drug costs climb

06-18-2015 Media

CalPERS said it spent nearly $40 million for Sovaldi on plans run by Blue Shield of California, Kaiser Permanente and CVS Health.

Skyrocketing drug prices leave cures out of reach for some patients

06-16-2015 Media

Sophisticated drugs are opening the door, scientists say, to an era of “precision medicine.” They’re also ushering in an age of astronomical prices.

National Coalition on Health Care highlights the impact of rising specialty drug prices

04-24-2015 Media

Originally published on AmericanPharmacyNews.com.

Speaking Engagements Broaden Discussion on Unsustainable Drug Prices

02-24-2015 MediaPress Release

John Rother to Make Appearances at AMA National Advocacy Conference and National Conference of Insurance Legislators. 

CVS girds for battle over cholesterol drugs

02-17-2015 Media

Drug retail giant CVS Health Corp. is girding to do battle with pharmaceutical companies over a coming class of cholesterol drugs that CVS says could cost the nation’s health-care system $150 billion a year.

On health-care prices, Obama goes where Obamacare doesn’t

02-9-2015 Media

Ever since Obamacare took effect, Republicans have warned of mission creep: that a law bringing more government regulation to health care would eventually morph into single-payer.

Doctors group joins fight against ‘skyrocketing’ drug prices

02-3-2015 Media

A national group of more than 140,000 physicians on Tuesday joined a coalition dedicated to reversing the growing trend of high-cost specialty drugs, which are being blamed for straining the finances of patients, insurance plans and public health coverage programs.

Obama’s Budget Targets High Cost of Cutting-Edge Drugs

02-2-2015 Media

With patients facing more exposure to the cost of revolutionary new medications, the budget President Barack Obama released Monday reopened a debate on whether government should use its buying power to squeeze the pharmaceutical industry for lower prices.

Gilead Sciences Earnings: What to Watch

02-2-2015 Media

Gilead Sciences Inc. is scheduled to announce its fourth-quarter earnings Feb. 3. Last year, Gilead’s Sovaldi had the top-selling drug launch in history with more than $8.5 billion in sales through the end of September.

Obama Health Budget Calls for Authority to Negotiate Drug Prices

02-2-2015 Media

The Obama administration’s fiscal 2016 budget request calls for allowing the government to negotiate the price of prescription drugs and giving regulators new funding to fight Ebola.

Sign-up for updates

  • This field is for validation purposes and should be left unchanged.